Facebook Linkedin RSS Twitter Youtube
Home 2022

Hemorrhagic fever

Lethal, Tick Borne, Hemorrhagic Fever Virus May Find Treatment in mAbs
Drug Discovery

Lethal, Tick Borne, Hemorrhagic Fever Virus May Find Treatment in mAbs

Julianna LeMieux, PhD -
0
Small Molecules Target Entry Mechanism for Deadly Viruses
Drug Discovery

Small Molecules Target Entry Mechanism for Deadly Viruses

Jeffrey S. Buguliskis, Ph.D. -
0
Dengue Shock Investigation Clears CD4 T Cells of Wrongdoing
Drug Discovery

Dengue Shock Investigation Clears CD4 T Cells of Wrongdoing

Kevin Mayer -
0
Viral Hemorrhagic Fever Treatment Developed
Drug Discovery

Viral Hemorrhagic Fever Treatment Developed

GEN Staff Writer -
0
Emergent Wins BARDA Contract to Develop Viral Hemorrhagic Fever Treatments
Drug Discovery

Emergent Wins BARDA Contract to Develop Viral Hemorrhagic Fever Treatments

GEN Staff Writer -
0
Engineered Antibodies Neutralize Two Deadliest Ebola Virus Strains
Drug Discovery

Engineered Antibodies Neutralize Two Deadliest Ebola Virus Strains

GEN Staff Writer -
0
High Cholesterol Good for Hantavirus
News

High Cholesterol Good for Hantavirus

GEN Staff Writer -
0
Alnylam to Receive $7.5M More under NIAID Contract for RNAi Drugs against Hemorrhagic Fever
News

Alnylam to Receive $7.5M More under NIAID Contract for RNAi Drugs against Hemorrhagic Fever

GEN Staff Writer -
0
Alnylam Wins $38.6M Contract to Develop RNAi Therapeutics for Hemorrhagic Fever
News

Alnylam Wins $38.6M Contract to Develop RNAi Therapeutics for Hemorrhagic Fever

GEN Staff Writer -
0
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.